CompuMed debuted its digital OsteoView 2000 bone densitometry scanner at the annual meeting of the American Society of Bone and Mineral Research held last week. OsteoView 2000 will allow diagnosis of both osteoporosis and arthritis, according to the
CompuMed debuted its digital OsteoView 2000 bone densitometry scanner at the annual meeting of the American Society of Bone and Mineral Research held last week. OsteoView 2000 will allow diagnosis of both osteoporosis and arthritis, according to the Manhattan Beach, CA-based company.
The scanner leverages off a set of image processing and segmentation tools developed by CompuMed, as well as direct digital x-ray capture technology developed by Varian Associates and Xerox under a grant from the U.S. Defense Advanced Research Projects Agency (DARPA). CompuMed has received exclusive rights to the technology in the fields of appendicular bone mass measurement and automated arthritis detection, according to CompuMed. Clinical trials will begin in October for OsteoView 2000, and the company expects to receive Food and Drug Administration 510(k) clearance in 1998.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.